{'52WeekChange': 0.7366688,
 'SandP52WeekChange': None,
 'address1': '5375 Medpace Way',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 105.78,
 'askSize': 900,
 'averageDailyVolume10Day': 306462,
 'averageVolume': 283376,
 'averageVolume10days': 306462,
 'beta': 1.221158,
 'beta3Year': None,
 'bid': 70,
 'bidSize': 1000,
 'bookValue': 20.343,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cincinnati',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 110.04,
 'dayLow': 105.4,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.508,
 'enterpriseToEbitda': 23.443,
 'enterpriseToRevenue': 4.122,
 'enterpriseValue': 3672926208,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '513 579 0444',
 'fiftyDayAverage': 94.83171,
 'fiftyTwoWeekHigh': 114.12,
 'fiftyTwoWeekLow': 58.72,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 26984011,
 'forwardEps': 3.56,
 'forwardPE': 29.72191,
 'fromCurrency': None,
 'fullTimeEmployees': 3600,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.23909001,
 'heldPercentInstitutions': 0.82433,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/medpace.com',
 'longBusinessSummary': 'Medpace Holdings, Inc., a clinical contract research '
                        'organization, provides scientifically-driven '
                        'outsourced clinical development services to the '
                        'biotechnology, pharmaceutical, and medical device '
                        'industries worldwide. The company offers a suite of '
                        'services supporting the clinical development process '
                        'from Phase I to Phase IV in various therapeutic '
                        'areas. It also provides clinical development '
                        'services; and development plan design, coordinated '
                        'central laboratory, project management, regulatory '
                        'affairs, clinical monitoring, data management and '
                        'analysis, pharmacovigilance new drug application '
                        'submissions, and post-marketing clinical support '
                        'services. The company also provides bio-analytical '
                        'laboratory services, clinical human pharmacology, '
                        'imaging services, and electrocardiography reading '
                        'support for clinical trials. Medpace Holdings, Inc. '
                        'was founded in 1992 and is headquartered in '
                        'Cincinnati, Ohio.',
 'longName': 'Medpace Holdings, Inc.',
 'market': 'us_market',
 'marketCap': 3742975744,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_260345878',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 109900000,
 'nextFiscalYearEnd': 1640908800,
 'open': 110.04,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 7.82,
 'phone': '513 579 9911',
 'previousClose': 110.73,
 'priceHint': 2,
 'priceToBook': 5.2012973,
 'priceToSalesTrailing12Months': 4.200366,
 'profitMargins': 0.12367,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 110.04,
 'regularMarketDayLow': 105.4,
 'regularMarketOpen': 110.04,
 'regularMarketPreviousClose': 110.73,
 'regularMarketPrice': 110.04,
 'regularMarketVolume': 394997,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 35374500,
 'sharesPercentSharesOut': 0.074,
 'sharesShort': 2617650,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2591541,
 'shortName': 'Medpace Holdings, Inc.',
 'shortPercentOfFloat': 0.24520001,
 'shortRatio': 10.29,
 'startDate': None,
 'state': 'OH',
 'strikePrice': None,
 'symbol': 'MEDP',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 2.919,
 'trailingPE': 36.248714,
 'twoHundredDayAverage': 87.914894,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'b158a4ab-e72e-3133-a90d-5be125173518',
 'volume': 394997,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.medpace.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '45227'}